Product Description
| CAS | 60832-72-6 |
| 化学式 | C6H4N2O2 |
| 分子量 | 136.11 |
| InChI | InChI=1/C6H4N2O2/c9-6-8-5-4(10-6)2-1-3-7-5/p-3H,(H,7,8,9) |
| 密度 | 1.59±0.1 g/cm3(Predicted) |
| 熔点 | 214 °C |
| 沸点 | 253.8±23.0 °C(Predicted) |
| 溶解度 | DMSO, Methanol |
| 折射率 | 1.595 |
| 酸度系数 | 2.76±0.20(Predicted) |
| 存储条件 | Sealed in dry,Room Temperature |
| 外观 | Solid |
| 颜色 | Tan |
| MDL号 | MFCD00204215 |
AI Product Description
*The following content is generated by AI and is for reference only.
2,3-Dihydropyrido[2,3-d][1,3]oxazol-2-one represents a specialized heterocyclic compound within the realm of medicinal chemistry and organic synthesis. While specific commercial availability may vary depending on regional suppliers and current stock levels, this molecule is primarily valued for its structural complexity and potential utility in pharmaceutical research. The compound features a fused bicyclic system comprising a pyridine ring linked to an oxazolidinone moiety, creating a rigid scaffold that is often explored for its ability to interact with biological targets.
The molecular formula for 2,3-dihydropyrido[2,3-d][1,3]oxazol-2-one is typically C6H4N2O2, reflecting its composition of six carbon atoms, four hydrogen atoms, two nitrogen atoms, and two oxygen atoms. Its precise CAS number is subject to verification through major chemical databases such as CAS Registry or PubChem, as variations in nomenclature or unsubstituted derivatives might lead to different registry entries; however, it generally falls under the classification of substituted pyridine-oxazole derivatives. This structural motif is frequently employed as a key intermediate in the total synthesis of more complex bioactive molecules, including various alkaloids and drug candidates targeting neurological disorders or antimicrobial pathways.
In laboratory settings, this compound serves as a critical building block for constructing libraries of heterocycles used in high-throughput screening assays. Researchers utilize its unique electronic properties and steric constraints to investigate structure-activity relationships (SAR) when developing new therapeutics. The presence of the lactam functionality within the oxazolone ring offers versatile sites for further chemical modification, allowing chemists to introduce diverse functional groups to enhance potency, selectivity, or pharmacokinetic profiles. Furthermore, derivatives of this core structure have shown promise in modulating enzyme activity and receptor binding, making them attractive subjects for academic inquiry and industrial drug discovery programs.
Although not currently a mainstream bulk chemical, 2,3-dihydropyrido[2,3-d][1,3]oxazol-2-one remains significant in the advanced stages of preclinical development. Its synthesis often involves cyclization reactions between amino-pyridine precursors and carbonylating agents, requiring careful control of reaction conditions to ensure high yield and purity. As the demand for novel heterocyclic scaffolds grows in the pursuit of innovative medicines, compounds like this continue to play a pivotal role in expanding the chemical space available for therapeutic innovation. Scientists worldwide rely on such specialized intermediates to push the boundaries of modern pharmacology and materials science.